IP Library Granted Patent US 9,555,121
Granted Patent B2
US 9,555,121 · App. 14/650,660 · Granted Jan 31, 2017

Composition for forming complex, complex formed therefrom, and composition for oral administration including said complex

Inventors: Sung Wan Lee (Incheon, KR); Jae Uk Cha (Seoul, KR); Jun Kee Hong (Yongin-si, KR); Hyon Ho Baek (Incheon, KR)
Assignee: LOTTE FINE CHEMICAL CO., LTD.
A61K47/38A61K9/4808A61K9/4866A61K9/4891A61K31/045A61K31/235A61K31/353A61K31/355A61K31/375A61K36/53A61K47/02A61K47/46A61K47/4823C08L1/02A61K47/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,555,121
App. No.
14/650,660
Granted
Jan 31, 2017
Kind
B2
Abstract

Provide are a composition for forming a composite, the composition including a cellulose-based compound, a polyphenol-based compound, and a solvent, wherein an amount of the polyphenol-based compound is 1 to 40 parts by weight based on 100 parts by weight of the cellulose-based compound, a composite formed from the composition, and an orally ingestible composition including the composite. The composite has characteristics of being dissolved in a solvent in a various pH ranges depending on a mixing ratio of the cellulose-based compound and the polyphenol-based compound. Therefore, when the composite is used, a composite film may be easily prepared, and the composite film may be useful in medical or foods fields where film characteristics dependent on pH is required.

Claims (21)

1. A composition for forming a composite, the composition comprising:

a cellulose-based compound,

a polyphenol-based compound,

an antioxidant selected from ascorbic acid, butylhydroxyanisole, erythorbic acid, propyl gallate, rosemary oil, dibutyl hydroxy toluene, quercetin, tocopherol, or a mixture thereof, in an amount of 1 to 10 parts by weight based on 100 parts by weight of the cellulose-based compound, and

a solvent,

wherein an amount of the polyphenol-based compound is 1 to 7.59 parts by weight based on 100 parts by weight of the cellulose-based compound,

wherein the cellulose-based compound is hydroxypropyl methylcellulose (HPMC), methylcellulose (MC), carboxymethylcellulose (CMC), a derivative thereof, or a mixture thereof,

wherein the polyphenol-based compound is selected from epigallocatechin gallate (EGCG), epicatechin gallate (ECG), epicatechin (EC), and epigallocatechin (EGC).

2. The composition of claim 1 , wherein the polyphenol-based compound is obtained from green tea extract.

3. The composition of claim 1 , wherein the solvent comprises at least one selected from water and ethanol, wherein an amount of the solvent is 100 to 2000 parts by weight based on 100 parts by weight of a total amount of the cellulose-based compound and the polyphenol-based compound.

4. The composition of claim 1 , the composition further comprising a pH controlling agent.

5. The composition of claim 4 , wherein the pH controlling agent is an alkaline agent comprising sodium hydroxide, potassium hydroxide, calcium hydroxide, or a mixture thereof.

6. A composite comprising

a cellulose-based compound,

a polyphenol-based compound, and

an antioxidant selected from ascorbic acid, butylhydroxyanisole, erythorbic acid, propyl gallate, rosemary oil, dibutyl hydroxy toluene, quercetin, tocopherol, or a mixture thereof, in an amount of 1 to 10 parts by weight based on 100 parts by weight of the cellulose-based compound,

wherein an amount of the polyphenol-based compound is 1 to 7.59 parts by weight based on 100 parts by weight of the cellulose-based compound,

wherein the cellulose-based compound is hydroxypropyl methylcellulose (HPMC), methylcellulose (MC), carboxymethylcellulose (CMC), a derivative thereof, or a mixture thereof,

wherein the polyphenol-based compound is selected from epigallocatechin gallate (EGCG), epicatechin gallate (ECG), epicatechin (EC), and epigallocatechin (EGC).

7. The composite of claim 6 , wherein the composite has a pH dependent solubility.

8. An orally ingestible composition comprising the composite of claim 6 .

Assignments (2)
CHANGE OF NAME Recorded May 17, 2016
From: SAMSUNG FINE CHEMICALS CO., LTD.
To: LOTTE FINE CHEMICAL CO., LTD.
Reel/Frame 038726/0289 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2015
From: LEE, SUNG WAN; CHA, JAE UK; HONG, JUN KEE; BAEK, HYON HO
To: SAMSUNG FINE CHEMICALS CO., LTD.
Reel/Frame 036576/0320 →
Priority Claims (2)
KR 10-2012-0143828 · Dec 11, 2012 · national
KR 10-2013-0149471 · Dec 3, 2013 · national
Continuity (1)
Related Publication 20150335755A1 · Nov 26, 2015